VERNALIS (R&D) LIMITED – Trademark Portfolio

Entity Type: 03

VERNALIS (R&D) LIMITED holds 23 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 23 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include APOKYN, MOXATAG, and VERNALIS. The owner is based in WINNERSH, WOKINGHAM, BERKSHIRE.

100 BERKSHIRE PLACE, WHARFEDALE ROAD

WINNERSH, WOKINGHAM, BERKSHIRE RG41 5RD , GB

23 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

VERNALIS (R&D) LIMITED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (23 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (5 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does VERNALIS (R&D) LIMITED have?

VERNALIS (R&D) LIMITED has 23 U.S. trademarks filed with the USPTO. Of these, 3 registered, 14 abandoned, 6 cancelled.

What trademark classes does VERNALIS (R&D) LIMITED file in?

VERNALIS (R&D) LIMITED files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are VERNALIS (R&D) LIMITED's most well-known trademarks?

VERNALIS (R&D) LIMITED's registered trademark portfolio includes well-known marks such as APOKYN, MOXATAG, and VERNALIS. These are among 3 currently registered trademarks in the portfolio.

What is VERNALIS (R&D) LIMITED's trademark registration success rate?

VERNALIS (R&D) LIMITED has a 13% trademark registration rate, with 3 out of 23 resolved applications resulting in successful registration. Currently, 0 applications are pending review.